Abstract
Angiogenesis is a critical event in the progression of human neuroblastoma. This mini-review summarizes our literature and experimental data concerning the use of anti-angiogenic molecules, such as TNP-470 and fenretinide, in neuroblastoma treatment.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Angiogenesis Inhibitors / therapeutic use*
-
Antineoplastic Agents / therapeutic use*
-
Fenretinide / therapeutic use*
-
Humans
-
Neovascularization, Pathologic / prevention & control*
-
Neuroblastoma / blood supply*
-
Neuroblastoma / drug therapy
Substances
-
Angiogenesis Inhibitors
-
Antineoplastic Agents
-
Fenretinide